SchultzSMillerDArndtSZiebellSGuptaSAndreasenN. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation. Biol Psychiatry1995;38: 713–9.
GardosGColeJPTarsyD. Withdrawal syndromes associated with antipsychotic drugs. Am J Psychiatry1978;135: 1321–4.
4.
DrayA. Serotonin in the basal ganglia: Functions and interactions with other neural pathways. J Physiol Paris1981;77: 393–403.
5.
Tardive dyskinesia: a task force report of the American Psychiatric Association. Washington, DC: American Psychiatric Association, 1992.
6.
AddingtonDEToewsJAAddingtonJM. Risperidone and tardive dyskinesia: A case report. J Clin Psychiatry1995;56: 484–5.
7.
BuzanRD. Risperidone-induced tardive dyskinesia. Am J Psychiatry1996;153: 734–5.
8.
FeeneyDJKlykyloW. Risperidone and tardive dyskinesia. J Am Acad Child Adolesc Psychiatry1996;35: 1421–2.
9.
WoernerMGSheitmanBBLiebermanJAKaneJM. Tardive dyskinesia induced by risperidone (letter). Am J Psychiatry1996;153: 843.
10.
GwinnKACavinessJN. Risperidone-induced tardive dyskinesia and parkinsonism. Mov Disord1997;12: 119–21.
11.
AnandVSDewanMJ. Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction. Ann Clin Psych1996;8: 179–82.
12.
GerberPELyndLD. Selective serotonin-reuptake inhibitor–induced movement disorders. Ann Pharmacother1998;32: 692–8.
13.
EganMFApudJWyattRJ. Treatment of tardive dyskinesia. Schizo Bull1997;23: 583–609.
14.
SaijadSH. Vitamin E in the treatment of tardive dyskinesia: A preliminary study over 7 months at different doses. Int Clin Psychopharm1998;13: 147–55.
15.
ThakerGKNguyenJAStraussMEJacobsonRKaupBATammingaCA. Clonazepam treatment of tardive dyskinesia: A practical GABA-mimetic strategy. Am J Psychiatry1990;147: 445–51.
16.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEAA method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30:239–45.
